Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cardiovascular Drugs and Therapy|July 1, 1997
Effects of almokalant, a class III antiarrhythmic agent, on supraventricular, reentrant tachycardias. Almokalant Paroxysmal Supraventricular Tachycardia Study GroupB Darpö, N Edvardsson
Journal of Cardiovascular Pharmacology|August 1, 1995
Effect of almokalant, a selective potassium channel blocker, on the termination and inducibility of paroxysmal supraventricular tachycardias: a study in patients with Wolff-Parkinson-White syndrome and atrioventricular nodal reentrant tachycardia. Almokalant PSVT Study GroupB Darpö, N Edvardsson
European Heart Journal|March 21, 1998
Modification of atrioventricular conduction as adjunct therapy for pacemaker-treated patients with hypertrophic obstructive cardiomyopathyF Gadler, C Linde, B Darpö
International Journal of Cardiology|March 1, 1996
Torsades de pointes induced by transesophageal atrial stimulation after administration of almokalantB Darpö, M Allared, N Edvardsson
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 28, 2001
Assessment of accessory pathway and atrial refractoriness by transoesophageal and intracardiac atrial stimulation: an analysis of methodological agreementK Nanthakumar, L Bergfeldt, B Darpö
European Heart Journal|August 5, 2000
The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillationM Frick, B Darpö, J Ostergren, et al.
Heart (British Cardiac Society)|February 23, 1999
Frequency and long term follow up of valvar insufficiency caused by retrograde aortic radiofrequency catheter ablation proceduresA Olsson, B Darpö, L Bergfeldt, et al.
The European Respiratory Journal|February 1, 1995
Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implicationsJ Hedner, B Darpö, H Ejnell, et al.
Cardiovascular Drugs and Therapy|November 1, 1996
Assessment of frequency dependency of the class III effects of almokalant: a study using programmed stimulation and recording of monophasic action potentials and ventricular paced QT intervalsB Darpö, O Almgren, R Bergstrand, et al.
British Heart Journal|September 1, 1995
Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillationM Edner, K Caidahl, L Bergfeldt, et al.
Pageof 2